The US extracellular matrix market represents a significant share of the North American market and is projected to grow at a CAGR of 7.6% during the forecast period. Market expansion in the US is associated with the rising prevalence of cardiovascular diseases, trauma, wounds, and surgical conditions, together with increasing utilization of advanced tissue-repair technologies. According to The...